Braun Bostich & Associates Inc. Abbott Laboratories Transaction History

Braun Bostich & Associates Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $3.17 Million - $3.86 Million	-27,764 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $3.21 Million - $3.93 Million	27,764 New	27,764 $3.52 Million
Q3 2020 Oct 09, 2020	SELL	$91.64 - $111.29 $14,937 - $18,140	-163 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $12,797 - $14,246	163 New	163 $14,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $25,288 - $27,420	-309 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $11,587 - $13,515	-159 Reduced 33.97%	309 $26,000
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $22,448 - $27,140	-339 Reduced 42.01%	468 $37,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $19,580 - $23,621	322 Added 66.39%	807 $59,000
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $13,471 - $14,868	234 Added 93.23%	485 $30,000
Q1 2018 May 16, 2018	BUY	$56.27 - $63.62 $14,123 - $15,968	251 New	251 $0

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

Stay updated on Braun Bostich & Associates Inc. with notifications on news.